These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 20147814

  • 1. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: a prospective clinical study.
    Lee CY, Suzuki JB.
    Implant Dent; 2010 Feb; 19(1):29-38. PubMed ID: 20147814
    [Abstract] [Full Text] [Related]

  • 2. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part I: biological concepts with a review of the literature.
    Lee CY, Suzuki JB.
    Implant Dent; 2009 Dec; 18(6):492-500. PubMed ID: 20009603
    [Abstract] [Full Text] [Related]

  • 3. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
    Lazarovici TS, Mesilaty-Gross S, Vered I, Pariente C, Kanety H, Givol N, Yahalom R, Taicher S, Yarom N.
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
    [Abstract] [Full Text] [Related]

  • 4. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
    Marx RE, Cillo JE, Ulloa JJ.
    J Oral Maxillofac Surg; 2007 Dec; 65(12):2397-410. PubMed ID: 18022461
    [Abstract] [Full Text] [Related]

  • 5. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
    Kunchur R, Need A, Hughes T, Goss A.
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
    [Abstract] [Full Text] [Related]

  • 6. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

  • 7. Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers?
    Kwon YD, Ohe JY, Kim DY, Chung DJ, Park YD.
    Clin Oral Implants Res; 2011 Jan; 22(1):100-5. PubMed ID: 20946206
    [Abstract] [Full Text] [Related]

  • 8. Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws.
    Lehrer S, Montazem A, Ramanathan L, Pessin-Minsley M, Pfail J, Stock RG, Kogan R.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Sep; 106(3):389-91. PubMed ID: 18554944
    [Abstract] [Full Text] [Related]

  • 9. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
    American Society for Bone and Mineral Research Task Force on Osteonecrosis of the Jaw, Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E.
    J Oral Maxillofac Surg; 2008 Jun; 66(6):1320-1; author reply 1321-2. PubMed ID: 18486811
    [No Abstract] [Full Text] [Related]

  • 10. Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw.
    Baim S, Miller PD.
    J Bone Miner Res; 2009 Apr; 24(4):561-74. PubMed ID: 19257812
    [Abstract] [Full Text] [Related]

  • 11. Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates.
    Bagan JV, Jiménez Y, Gómez D, Sirera R, Poveda R, Scully C.
    Oral Oncol; 2008 Nov; 44(11):1088-9. PubMed ID: 18396443
    [Abstract] [Full Text] [Related]

  • 12. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.
    Abu-Id MH, Warnke PH, Gottschalk J, Springer I, Wiltfang J, Acil Y, Russo PA, Kreusch T.
    J Craniomaxillofac Surg; 2008 Mar; 36(2):95-103. PubMed ID: 18234504
    [Abstract] [Full Text] [Related]

  • 13. Serum CTX testing.
    Schwartz HC.
    J Oral Maxillofac Surg; 2008 Jun; 66(6):1319-20; author reply 1320. PubMed ID: 18486810
    [No Abstract] [Full Text] [Related]

  • 14. A review of the clinical implications of bisphosphonates in dentistry.
    Borromeo GL, Tsao CE, Darby IB, Ebeling PR.
    Aust Dent J; 2011 Mar; 56(1):2-9. PubMed ID: 21332734
    [Abstract] [Full Text] [Related]

  • 15. Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws.
    Kwon YD, Kim DY, Ohe JY, Yoo JY, Walter C.
    J Oral Maxillofac Surg; 2009 Dec; 67(12):2644-8. PubMed ID: 19925985
    [Abstract] [Full Text] [Related]

  • 16. [Bisphosphonates and osteonecrosis of the jaws].
    Urade M.
    Clin Calcium; 2007 Feb; 17(2):241-8. PubMed ID: 17272882
    [Abstract] [Full Text] [Related]

  • 17. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?
    Brown JJ, Ramalingam L, Zacharin MR.
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):863-7. PubMed ID: 18221397
    [Abstract] [Full Text] [Related]

  • 18. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T, Cheng A, Stein B, Goss A.
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [Abstract] [Full Text] [Related]

  • 19. CTX and its role in managing patients exposed to oral bisphosphonates.
    Dodson TB.
    J Oral Maxillofac Surg; 2010 Feb; 68(2):487-8; author reply 488-9. PubMed ID: 20116729
    [No Abstract] [Full Text] [Related]

  • 20. Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients.
    Kyrgidis A, Vahtsevanos K, Koloutsos G, Andreadis C, Boukovinas I, Teleioudis Z, Patrikidou A, Triaridis S.
    J Clin Oncol; 2008 Oct 01; 26(28):4634-8. PubMed ID: 18574158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.